JP2009523124A - 置換されたイミダゾリン誘導体 - Google Patents

置換されたイミダゾリン誘導体 Download PDF

Info

Publication number
JP2009523124A
JP2009523124A JP2008546224A JP2008546224A JP2009523124A JP 2009523124 A JP2009523124 A JP 2009523124A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2009523124 A JP2009523124 A JP 2009523124A
Authority
JP
Japan
Prior art keywords
dimethylamino
phenyl
dihydro
imidazole
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008546224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523124A5 (https=
Inventor
マーラ・ベアトリクス
オーバーベルシュ・シュテファン
ズンダーマン・ベルント
エングルベルガー・ヴェルナー
ヘンニース・ハーゲン−ハインリヒ
グラウバウム・ハインツ
Original Assignee
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング filed Critical グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Publication of JP2009523124A publication Critical patent/JP2009523124A/ja
Publication of JP2009523124A5 publication Critical patent/JP2009523124A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2008546224A 2005-12-22 2006-12-19 置換されたイミダゾリン誘導体 Ceased JP2009523124A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061430A DE102005061430A1 (de) 2005-12-22 2005-12-22 Substituierte Imidazolin-Derivate
PCT/EP2006/012221 WO2007079927A1 (de) 2005-12-22 2006-12-19 Substituierte imidazolin-derivate

Publications (2)

Publication Number Publication Date
JP2009523124A true JP2009523124A (ja) 2009-06-18
JP2009523124A5 JP2009523124A5 (https=) 2012-12-13

Family

ID=37946192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546224A Ceased JP2009523124A (ja) 2005-12-22 2006-12-19 置換されたイミダゾリン誘導体

Country Status (17)

Country Link
US (1) US7728028B2 (https=)
EP (1) EP1963278B1 (https=)
JP (1) JP2009523124A (https=)
CN (1) CN101384557A (https=)
AT (1) ATE449075T1 (https=)
AU (1) AU2006334743B2 (https=)
CA (1) CA2633918A1 (https=)
CY (1) CY1110465T1 (https=)
DE (2) DE102005061430A1 (https=)
DK (1) DK1963278T3 (https=)
ES (1) ES2336833T3 (https=)
IL (1) IL192268A0 (https=)
PL (1) PL1963278T3 (https=)
PT (1) PT1963278E (https=)
RU (1) RU2427571C2 (https=)
SI (1) SI1963278T1 (https=)
WO (1) WO2007079927A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5599774B2 (ja) 2008-03-27 2014-10-01 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヒドロキシメチルシクロヘキシルアミン類
ATE537143T1 (de) 2008-03-27 2011-12-15 Gruenenthal Gmbh Spiro(5.5)undecan derivate
PT2260042E (pt) 2008-03-27 2011-12-06 Gruenenthal Gmbh Derivados de ciclo-hexano espirocíclicos substituídos
WO2009118174A1 (de) 2008-03-27 2009-10-01 Grünenthal GmbH Substituierte cyclohexyldiamine
CA2719735A1 (en) 2008-03-27 2009-10-01 Gruenenthal Gmbh Substituted 4-aminocyclohexane derivatives
AU2009228637B2 (en) 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513556A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー ニューロパシー痛の治療方法
JP2001513532A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 痛みを処置するための方法
JP2003519210A (ja) * 2000-01-05 2003-06-17 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 置換アミノメチル−フェニル−シクロヘキサン誘導体
WO2004066996A1 (en) * 2003-01-17 2004-08-12 Michigan State University NF-kB INHIBITORS AND USES THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7183276B2 (en) * 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513556A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー ニューロパシー痛の治療方法
JP2001513532A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 痛みを処置するための方法
JP2003519210A (ja) * 2000-01-05 2003-06-17 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 置換アミノメチル−フェニル−シクロヘキサン誘導体
WO2004066996A1 (en) * 2003-01-17 2004-08-12 Michigan State University NF-kB INHIBITORS AND USES THEREOF

Also Published As

Publication number Publication date
AU2006334743B2 (en) 2011-07-07
WO2007079927A1 (de) 2007-07-19
ATE449075T1 (de) 2009-12-15
ES2336833T3 (es) 2010-04-16
US7728028B2 (en) 2010-06-01
CN101384557A (zh) 2009-03-11
CA2633918A1 (en) 2007-07-19
PL1963278T3 (pl) 2010-04-30
SI1963278T1 (sl) 2010-03-31
DE102005061430A1 (de) 2007-07-05
CY1110465T1 (el) 2015-04-29
IL192268A0 (en) 2008-12-29
HK1122019A1 (zh) 2009-05-08
PT1963278E (pt) 2009-12-16
RU2008129377A (ru) 2010-03-27
US20090048323A1 (en) 2009-02-19
EP1963278B1 (de) 2009-11-18
EP1963278A1 (de) 2008-09-03
AU2006334743A1 (en) 2007-07-19
DK1963278T3 (da) 2010-03-29
DE502006005426D1 (de) 2009-12-31
RU2427571C2 (ru) 2011-08-27

Similar Documents

Publication Publication Date Title
JP4791374B2 (ja) スピロ環状シクロヘキサン誘導体
JP4885733B2 (ja) Orl1レセプターに対する親和性を有するスピロ環状シクロヘキサン誘導体
US8124788B2 (en) Spirocyclic cyclohexane compounds with analgesic activity
US5352788A (en) N-substituted heterocyclic derivatives
RU2176640C2 (ru) Гетероциклические соединения или их фармацевтически приемлемая соль, промежуточные соединения
JP5599774B2 (ja) ヒドロキシメチルシクロヘキシルアミン類
US7589113B2 (en) Substituted oxadiazole compounds and their use as opioid receptor ligands
JP4458853B2 (ja) Nk1アンタゴニスト
JP4982357B2 (ja) ヘテロアリール−置換されたシクロヘキシル−1,4−ジアミン誘導体
IL103116A (en) History of N-transformed heterocyclics, pharmaceutical preparations containing certain compounds and their preparation
US7728028B2 (en) Substituted imidazoline compounds
JP2007536319A (ja) 置換されたシクロヘキシル酢酸誘導体
AU691057B2 (en) 3-alkoxybenzylpiperidine derivatives as melatonergic agents
EA015974B1 (ru) Производные пирролизина, индолизина и хинолизина, их получение и их применение в терапии
JP4874237B2 (ja) 置換されたシクロヘキシルカルボン酸誘導体
JP6216385B2 (ja) 3,4−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用
JP5037336B2 (ja) 鎖長が延ばされ、置換されたシクロヘキシル−1,4−ジアミンの酸誘導体
JP2009520718A (ja) 鎮痛作用を有する置換されたオキサゾール誘導体
US6005118A (en) Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AU2002221632B8 (en) 5-amino-1-pentene-3-ol substituted derivatives
MX2008008067A (en) Substituted imidazoline derivatives
WO2002014272A1 (en) (thio)urea derivatives, process for their production and medicines containing the derivatives
AU723180B2 (en) Novel compound with platelet aggregation inhibitor activity
WO1995029910A1 (fr) Derive d'imidazolidinedione
HK1122019B (en) Substituted imidazoline derivatives

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090820

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121016

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121023

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121029

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121211

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20130514